14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $136.19 $156.84 Thursday, 25th Apr 2024 ASND stock ended at $136.93. This is 4.37% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.23% from a day low at $136.19 to a day high of $140.59.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Oct 25, 2023 $87.28 $87.45 $85.38 $86.30 208 209
Oct 24, 2023 $87.42 $89.12 $86.50 $88.05 164 627
Oct 23, 2023 $90.00 $90.06 $85.29 $87.14 220 255
Oct 20, 2023 $88.97 $90.80 $88.62 $90.00 176 388
Oct 19, 2023 $90.91 $92.88 $88.45 $89.92 321 831
Oct 18, 2023 $94.24 $95.41 $90.85 $91.08 234 892
Oct 17, 2023 $94.09 $95.99 $93.32 $94.52 161 361
Oct 16, 2023 $94.00 $95.08 $92.39 $94.09 146 581
Oct 13, 2023 $93.48 $95.58 $92.02 $93.57 142 089
Oct 12, 2023 $95.22 $96.15 $92.10 $93.13 316 941
Oct 11, 2023 $93.99 $94.87 $92.09 $94.74 223 258
Oct 10, 2023 $91.08 $94.47 $90.65 $93.61 226 357
Oct 09, 2023 $89.89 $91.36 $88.82 $91.03 154 665
Oct 06, 2023 $89.45 $92.17 $89.30 $90.48 188 933
Oct 05, 2023 $85.62 $90.12 $85.62 $90.02 401 800
Oct 04, 2023 $87.91 $88.00 $85.78 $86.10 273 629
Oct 03, 2023 $90.77 $91.90 $86.86 $87.91 317 685
Oct 02, 2023 $93.00 $93.10 $89.41 $91.13 298 537
Sep 29, 2023 $95.66 $95.79 $92.83 $93.64 234 525
Sep 28, 2023 $94.06 $95.04 $91.59 $94.95 201 587
Sep 27, 2023 $94.74 $95.32 $92.69 $94.07 194 940
Sep 26, 2023 $95.69 $96.54 $94.00 $94.21 330 553
Sep 25, 2023 $94.41 $96.68 $93.01 $95.50 178 771
Sep 22, 2023 $96.20 $97.11 $94.58 $95.06 307 549
Sep 20, 2023 $98.09 $99.47 $95.58 $95.60 178 476
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT